$66.06
-0.030%Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. The company offers VisionPro software, a suite of patented vision tools for advanced programming; QuickBuild that allows customers to build vision applications with a graphical, flowchart-based programming interface; and Cognex deep learning vision software. It also provides a range of inspection tasks, including part location, identification, measurement, assembly verification, and robotic guidance; vision sensors for vision applications, such as checking the presence and size of parts; and the In-Sight product line of vision systems and sensors. In addition, the company offers DataMan, an image-based barcode readers and barcode verifiers. It sells its products to consumer electronics, automotive, consumer products, food and beverage, pharmaceuticals, and medical devices industries, as well as through a network of distributors and integrators. Cognex Corporation was incorporated in 1981 and is headquartered in Natick, Massachusetts.
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Healthy operating margins demonstrate effective cost control and strong business fundamentals.
Strong net margins indicate efficient operations and favorable tax/interest management.
Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.
High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.
CGNX โข NASDAQ
| Cognex Corporation Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||||||
994.4M | 914.5M | 837.5M | 1B | 1B | 811M | 725.6M | 806.3M | 766.1M | 529.5M | 450.6M | 426.4M | 307.7M | 324.3M | 321.9M | 290.7M | 175.7M | 242.7M | 225.7M | 238.3M | |
GROSS PROFIT | ||||||||||||||||||||
(329M) | (288.7M) | (236.3M) | (284.2M) | (277.3M) | (206.4M) | (189.8M) | (206.1M) | (187.3M) | (131.1M) | (102.6M) | (94.1M) | (62.9M) | (79.5M) | (77.9M) | (77.6M) | (56.4M) | (68.4M) | (64.4M) | (64.8M) | |
665.4M | 625.8M | 601.2M | 721.9M | 759.8M | 604.6M | 535.9M | 600.3M | 578.8M | 398.4M | 348M | 332.4M | 244.8M | 244.8M | 244M | 213.1M | 119.3M | 174.3M | 161.3M | 173.5M | |
OPERATING INCOME | ||||||||||||||||||||
(502.8M) | (510.7M) | (470.5M) | (475.7M) | (444.7M) | (434.1M) | (393.3M) | (379.1M) | (319.9M) | (244.4M) | (226.5M) | (204.5M) | (167.8M) | (161.4M) | (158.6M) | (137.4M) | (132M) | (149.1M) | (133.2M) | (129M) | |
(363.9M) | (370.9M) | (339.1M) | (312.1M) | (309.4M) | (267.6M) | (273.8M) | (262.7M) | (220.7M) | (166.1M) | (156.7M) | (148.7M) | (123.5M) | (119.8M) | (117.7M) | (104.2M) | (96.4M) | (112.6M) | (99.8M) | (96.7M) | |
(139M) | (139.8M) | (139.4M) | (141.1M) | (135.4M) | (131M) | (119.4M) | (116.4M) | (99.2M) | (78.3M) | (69.8M) | (55.8M) | (44.3M) | (41.5M) | (40.9M) | (33.1M) | (31.1M) | (36.3M) | (33.4M) | (32.3M) | |
162.6M | 115.1M | 130.7M | 246.2M | 315.1M | 170.5M | 142.6M | 221.1M | 258.9M | 154.1M | 121.5M | 127.9M | 76.9M | 83.4M | 85.4M | 75.7M | -12.7M | 25.1M | 28.1M | 44.5M | |
PRE-TAX INCOME | ||||||||||||||||||||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.9M | 1.4M | 2.2M | 7.1M | 0.0 | 0.0 | |
(0.0) | (0.0) | -8M | (22.4M) | (0.0) | (35.5M) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (75K) | (4.5M) | (258K) | (0.0) | (0.0) | |
20.2M | 16.4M | 4.6M | 4.5M | 3.8M | 16.4M | 20.4M | 13.4M | 7.6M | 8M | 5.4M | 3.9M | 1.5M | 3.2M | 1.8M | 390K | 2.3M | 10.3M | 8M | 6.1M | |
182.8M | 131.5M | 135.3M | 250.7M | 318.9M | 186.9M | 163M | 234.6M | 266.5M | 162.1M | 127M | 131.8M | 78.5M | 86.6M | 87.1M | 76.1M | -10.4M | 35.4M | 36.1M | 50.6M | |
NET INCOME | ||||||||||||||||||||
(68.4M) | (25.3M) | (22.1M) | (35.2M) | (39M) | (10.7M) | -40.9M | (15.3M) | (89.8M) | (18.1M) | (19.3M) | (20.9M) | (11.3M) | (18.5M) | (17.2M) | (14.7M) | -5.5M | (4.9M) | (8.6M) | (10.5M) | |
114.4M | 106.2M | 113.2M | 215.5M | 279.9M | 176.2M | 203.9M | 219.3M | 176.7M | 143.7M | 187.1M | 121.5M | 73.6M | 68.1M | 69.9M | 61.4M | -4.9M | 27.3M | 26.9M | 39.9M |
CGNX - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q2 Q2 | May 07, 2026 | April 05, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 06, 2026 | May 06, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 29, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | March 13, 2026 | April 29, 2026 | 2026 | |
8-K/A 8-K/A 2025 (Amended) N/A | February 19, 2026 | October 29, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 17, 2026 | February 11, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 12, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 11, 2026 | February 11, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 03, 2025 | October 29, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | October 30, 2025 | September 28, 2025 | 2025 |
Continue your CGNX research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.